Consensus Recommendations for Management and Counseling of Adverse Events Associated With Lorlatinib: A Guide for Healthcare Practitioners

Resistance to first- and second-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) and development and progression of central nervous system metastases remain significant issues in the treatment of ALK-positive non-small-cell lung cancer. Lorlatinib is a novel third-genera...

Descripción completa

Detalles Bibliográficos
Autores principales: Reed, Mollie, Rosales, Aimee-Lauren S., Chioda, Marc D., Parker, Lindsey, Devgan, Geeta, Kettle, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Practical Approach
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467446/
https://www.ncbi.nlm.nih.gov/pubmed/32399810
http://dx.doi.org/10.1007/s12325-020-01365-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467446/
https://www.ncbi.nlm.nih.gov/pubmed/32399810
http://dx.doi.org/10.1007/s12325-020-01365-3

Ejemplares similares